Solid lipid nanoparticles: An effective lipid-based technology for cancer treatment
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Solid lipid nanoparticles (SLN) are considered at the forefront of nanotechnology's rapidly developing field, with several potential applications in drug delivery and research. SLN possesses promising attributes for reaching the goal of controlled and site-specific drug delivery and hence attracted researchers' wide attention. The present review briefly introduces SLN and discusses the reasoning behind the use of SLN over other colloidal carriers, such as emulsions and liposomes. Techniques to produce SLN, drug incorporation, loading capacity, and drug release mechanisms are reviewed. Aspects of the SLNs route of administration and the in vivo fate of the carriers are also discussed. The potential of SLN in incorporating different anti-cancer drugs and their effectiveness in various cancer therapies is highlighted. The mechanism of action of some commonly used anti-cancer agents with SLN is provided.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Retinoic acid in the development, regeneration and maintenance of the nervous system
Maden, M. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2212 · Cited by 896
Retinoid signalling in the development of the central nervous system
Maden, M. (2002) · Nature Reviews Neuroscience · doi:10.1038/nrn963 · Cited by 428
Retinoids in cancer therapy and chemoprevention: Promise meets resistance
Freemantle, S. J., Spinella, M. J., & Dmitrovsky, E. (2003) · Oncogene · doi:10.1038/sj.onc.1206936 · Cited by 312
SCHULZE‐TANZIL, G., MOBASHERI, A., SENDZIK, J., JOHN, T., & SHAKIBAEI, M. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1329.067 · Cited by 92
Cited by
Functionalized Nanomaterials Capable of Crossing the Blood–Brain Barrier
Zha, S., Liu, H., Li, H., Li, H., Wong, K.-L., & All, A. H. (2024) · ACS Nano · doi:10.1021/acsnano.3c10674 · Cited by 378
Samad, M. A., Ahmad, I., Zughaibi, T. A., Suhail, M., Zaidi, S. K., Al-Abbasi, F. A., & Tabrez, S. (2025) · European Journal of Medicinal Chemistry Reports · doi:10.1016/j.ejmcr.2025.100268 · Cited by 35
Vishwakarma, K. K., Hafeez, A., Usmani, S. A., Noor, L., & Khan, I. R. (2025) · Current Pharmaceutical Biotechnology · doi:10.2174/0113892010318524240907135527 · Cited by 4
Metadata
- Authors
- Akanda, M., Mithu, M. S. H., & Douroumis, D.
- Venue
- Journal of Drug Delivery Science and Technology
- Publisher
- Elsevier BV
- Published
- 2023-09
- Volume
- 86
- Pages
- 104709
- ISSN
- 1773-2247 (ISSN-L)
- OpenAlex
- W4382934801
- Cited by
- 156
- References
- 4
- FWCI
- 8.53
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Solid lipid nanoparticles: An effective lipid-based technology for cancer treatment. https://app.cochat.ai/papers/10.1016/j.jddst.2023.104709
- The paper
- Akanda, M., Mithu, M. S. H., & Douroumis, D. (2023). Solid lipid nanoparticles: An effective lipid-based technology for cancer treatment. Journal of Drug Delivery Science and Technology. https://doi.org/10.1016/j.jddst.2023.104709
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.